Global ENT endoscopy Market size is expected to be worth around US$ 18.4 Billion by 2035 from US$ 9.9 Billion in 2025 ...
IL-13 and TNF-α gene variants to chronic rhinosinusitis with nasal polyps and comorbid severe asthma, identifying three ...
Both full and limited endoscopic sinus surgery significantly improve quality of life in patients with chronic rhinosinusitis with nasal polyps, according to a recent study published in Allergy. In ...
Most people with chronic rhinosinusitis with nasal polyps (CRSwNP) are able to control their symptoms by using medicines that are sprayed into the nose or taken by mouth. But some people with this ...
Dupixent can be used for several conditions, once of which is treating ongoing nasal and sinus inflammation due to nasal polyps. It can be used for both adults and certain children. Dupixent is an ...
Discover expert-backed insights on fitness, nutrition, sleep, and healthy aging to help you feel your best—every day, at every stage of life. Discover expert-backed insights on fitness, nutrition, ...
Tezepelumab-ekko is now approved for chronic rhinosinusitis with nasal polyps (CRSwNP), targeting thymic stromal lymphopoietin and marking its second indication after severe asthma. The phase 3 ...
Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma. The FDA has now approved it as an add-on treatment for adults and ...
Please provide your email address to receive an email when new articles are posted on . Nasal polyp and congestion scores dropped more with stapokibart vs. placebo. Overall nasal symptoms, sense of ...
Addition of the monoclonal antibody stapokibart significantly improved nasal polyps and nasal congestion in adults with uncontrolled chronic rhinosinusitis with nasal polyps, based on new data from ...
For severe chronic rhinosinusitis with nasal polyps, the novel monoclonal antibody stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid. The polyp size ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results